211 related articles for article (PubMed ID: 8604269)
21. Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.
Karimi M; Giti R; Haghpanah S; Azarkeivan A; Hoofar H; Eslami M
Pediatr Blood Cancer; 2009 Dec; 53(6):1064-7. PubMed ID: 19533641
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentation of thalassemia major due to homozygous beta (0)-thalassemia.
Galanello R; Cossu P; Pirastu M; Cao A
Nouv Rev Fr Hematol (1978); 1981; 23(2):101-6. PubMed ID: 7290983
[TBL] [Abstract][Full Text] [Related]
23. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
Abdulwahid DA; Hassan MK
Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
[TBL] [Abstract][Full Text] [Related]
24. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
[TBL] [Abstract][Full Text] [Related]
25. Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation.
Ladis V; Karagiorga-Lagana M; Tsatra I; Chouliaras G
Eur J Haematol; 2013 Apr; 90(4):313-22. PubMed ID: 23331260
[TBL] [Abstract][Full Text] [Related]
26. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
27. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
Darwish HM; El-Khatib FF; Ayesh S
Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
[TBL] [Abstract][Full Text] [Related]
28. The relevance of ethnic monitoring in the experience of Haringey Healthcare NHS trust community family planning clinics.
Christopher E
Br J Fam Plann; 1999 Jan; 24(4):123-7. PubMed ID: 10023096
[TBL] [Abstract][Full Text] [Related]
29. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia.
Napoli N; Carmina E; Bucchieri S; Sferrazza C; Rini GB; Di Fede G
Bone; 2006 Jun; 38(6):888-92. PubMed ID: 16464653
[TBL] [Abstract][Full Text] [Related]
30. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
[TBL] [Abstract][Full Text] [Related]
31. Survival and complications in thalassemia.
Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
[TBL] [Abstract][Full Text] [Related]
32. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
33. Clinical phenotypes and genotypes diagnosis of thalassemia in children.
Torcharus K; Sriphaisal T; Krutvecho T; Suwanasophon C; Intarapakawong J
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():275-7. PubMed ID: 8629123
[TBL] [Abstract][Full Text] [Related]
34. Identification of candidate genes involved in clinical variability among Tunisian patients with β-thalassemia.
Mejri A; Siala H; Ouali F; Bibi A; Messaoud T
Gene; 2012 Sep; 506(1):166-72. PubMed ID: 22771911
[TBL] [Abstract][Full Text] [Related]
35. Quality of life in patients with thalassemia intermedia compared to thalassemia major.
Pakbaz Z; Treadwell M; Yamashita R; Quirolo K; Foote D; Quill L; Singer T; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():457-61. PubMed ID: 16339697
[TBL] [Abstract][Full Text] [Related]
36. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
37. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.
Helley D; Eldor A; Girot R; Ducrocq R; Guillin MC; Bezeaud A
Thromb Haemost; 1996 Sep; 76(3):322-7. PubMed ID: 8883264
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.
Taher A; Isma'eel H; Mehio G; Bignamini D; Kattamis A; Rachmilewitz EA; Cappellini MD
Thromb Haemost; 2006 Oct; 96(4):488-91. PubMed ID: 17003927
[TBL] [Abstract][Full Text] [Related]
39. [Beta-thalassemia: clinical manifestations].
Perrimond H
Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
[TBL] [Abstract][Full Text] [Related]
40. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
